The coronavirus (covid-19) current therapy market is forecasted to achieve growth in the coming few years with a forecast CAGR (compound annual growth rate) of -44%, as per The Business Research Company’s market report!

Read More On The Coronavirus (COVID-19) Current Therapy Market Report 2022 – https://www.thebusinessresearchcompany.com/report/coronavirus-current-therapy-global-market-report

The Coronavirus (COVID-19) Current Therapy Market Size In 2022 And Forecast

The global coronavirus (covid-19) current therapy market is expected to grow from $28.16 billion in 2021 to $16.43 billion in 2022 at a compound annual growth rate (CAGR) of -41.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The coronavirus (COVID-19) current therapy market is expected to decline to $1.57 billion in 2026 at a CAGR of -44.4%.

The coronavirus (COVID-19) current therapy market consists of sales of drugs currently used for the treatment of COVID-19 infection.

Request for A Sample Of The Global Coronavirus (COVID-19) Current Therapy Market Report:

 https://www.thebusinessresearchcompany.com/sample.aspx?id=3247&type=smp

Outbreak Of The Pandemic COVID-19 Is Driving The Growth Of The Coronavirus (COVID-19) Current Therapy Market

According to the World Health Organization (WHO), there were 10,719,946 cases of COVID-19 including 517,337 deaths reported to WHO as on 3rd July 2020, and this number is expected to grow soon. As there is no officially approved drug for COVID-19, the demand has risen significantly for repurposed drugs that are used for corona therapy. Countries across the world are facing shortages of drugs and the drug manufacturers are ramping up production to meet the global demand. The Coronavirus Treatment Acceleration Program (CTAP) is a special emergency program initiated by the FDA for the development of potential COVID-19 therapies to be made available to the patients as quickly as possible.

Competitive Landscape And The Regional Analysis Of The Coronavirus (COVID-19) Current Therapy Market

Major players in the coronavirus (covid-19) current therapy market are Moderna Therapeutics, Novavax, Bravovax, Ascletis Pharma, Altimmune, Clover Biopharmaceuticals, Inovio Pharmaceuticals, Inc., Biocryst Pharma, Gilead Sciences, and Regeneron Pharmaceuticals.

Additionally, as per TBRC’s research – North America was the largest region in the coronavirus (covid-19) current therapy market in 2021 holding the largest market share and Middle East is expected to be the fastest-growing region in the forecast period.

The Coronavirus (COVID-19) Current Therapy Global Market Report 2022  covers regional data on key drivers, opportunities, and strategies for the seven major regions of the world that are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the coronavirus (covid-19) current therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The report includes market size and forecast market shares for all the regions and countries with respect to the major players of the coronavirus (covid-19) current therapy market.

Convalescent Plasma Therapy – A Key Trend In The Coronavirus (COVID-19) Current Therapy Market

The blood plasma of patients who have recovered from a disease is called convalescent plasma (CP). Convalescent Plasma therapy is a type of passive antibody therapy in which blood plasma is isolated from patients who have recovered from the disease of interest and administered to the patient with severe disease to suppress the virulence and improve clinical symptoms. The blood plasma of recovered COVID-19 patients has antibodies to fight COVID-19 infection.

Coronavirus (COVID-19) Current Therapy Market Segmentation By The Business Research Company

1) By Drug Type: Remdesivir, Hydroxychloroquine, Ritonavir, Lopinavir, Interferon Beta, Others

2) By Route of Administration: Oral, Intravenous

3) By End-User: Hospitals, Clinics, Research Institutes, Others

Here Are Some Reports Related To The Coronavirus (COVID-19) Current Therapy Market –

Multiple Sclerosis Drugs Global Market Report 2022

Drugs For Immunotherapy Global Market Report 2022

Therapeutic Proteins Global Market Report 2022

Get In Touch With Us – Call us at:

Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708

Found this article helpful? Share it on: